SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences submits postal ballot notice

11 Nov 2025 Evaluate
Zydus Lifesciences has informed that further to the earlier intimation dated November 6, 2025 informing about the decision of the board of directors of Zydus Lifesciences (the Company) for raising of funds by way of issuance of eligible securities of the Company for an aggregate amount not exceeding Rs 5,000 Crores (Rupees Five Thousand Crores only) in one or more tranches by way of qualified institutions placement(s), rights issue, preferential allotment or a private placement(s) and / or any combination thereof or any other method as may be permitted under applicable laws, subject to the approval of the members of the Company and such regulatory / statutory approvals as may be required, to the eligible investors and pursuant to the provisions of regulation 30 of the Listing Regulations, it has attached the Postal Ballot Notice for seeking approval of the members by way of special resolution for the aforesaid matter. In compliance with the General Circulars dated April 8, 2020, April 13, 2020, and subsequent circulars issued in this regard, the latest being General Circular dated September 22, 2025 issued by the Ministry of Corporate Affairs, Postal Ballot Notice is being sent only through electronic mode to those members whose e-mail addresses are registered with the Company / Depositories and whose names are recorded in the Register of Members or Register of Beneficial Owners maintained by the Depositories as on Friday, November 7, 2025 (Cut-off date).

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

923.10 7.65 (0.84%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×